Electronic devices that measure blood pressure (BP) at the arm level are regarded as more accurate than wrist devices and are preferred for home BP (HBP) monitoring. Recently, wrist devices with position sensors have been successfully validated using established protocols. This study assessed whether HBP values measured with validated wrist devices are sufficiently reliable to be used for making patient-related decisions in clinical practice.
Self-monitoring of blood pressure (BP) by patients at home has been endorsed by several hypertension societies as a useful adjunct to office measurements, and these home BP (HBP) measurements are being increasingly used in clinical practice. [1] [2] [3] [4] For HBP monitoring, the 2003 European Society of Hypertension guidelines recommended that it is preferable to use validated semi-automatic devices that measure BP at the arm rather than at the wrist level. 5 This is because none of the wrist devices available at that time had been validated satisfactorily. 5 The main source of inaccuracy of wrist manometers appears to be related to uncertainty regarding the arm position. [6] [7] [8] Wrist measurements are also influenced by flexion and hyperextension of the wrist. 8, 9 Recent technological advances provided wrist devices fitted with position sensors that allow self-measurements to be taken only when the devices are at heart level. Recently, three devices with position sensors [10] [11] [12] [13] [14] and two without 15, 16 have been successfully validated in research settings, using established protocols. Consequently, in the 2007 European Society of Hypertension guidelines it is recommended that validated wrist devices can also be used for self-home monitoring of BP by patients, and that these measurements would be valid for use in clinical practice. 1 articles
Wrist Blood Pressure Monitors
The validation protocols require the accuracy of BP monitors to be tested in strictly controlled conditions. 17 It is questionable, however, whether in real-life conditions HBP measurements taken by wrist monitors can be adequately standardized to provide the same information as conventional arm devices.
This study assessed the reliability of HBP measurements recorded by patients using validated wrist devices with position sensors, in comparison with home measurements taken using validated arm devices, and with ambulatory BP monitoring.
Methods
Study design. Subjects were invited to participate in a randomized crossover study involving the assessment of BP with measurements in the clinic, at home using validated wrist and arm devices, and by ambulatory BP (ABP) monitoring. All ABP measurements and the ones recorded at home were taken on the left side (arm and wrist) within a duration of 2 weeks. A medical record was maintained, including measurements of weight, height, waist circumference, hip circumference, brachial and wrist circumferences, and BP. Participants were randomized (random numbers code list) to self-monitor their HBP using a wrist device (wrist-HBP) or arm device (arm-HBP). At the end of one HBP-monitoring session (either arm device or wrist device), 24-h-ABP monitoring was performed. This was followed by a second HBP monitoring session, this time using the device other than the one first used (Figure 1) .
Subjects.
Adult individuals who were referred to the outpatient hypertension clinic for elevated BP, whether under treatment or not, were recruited. Exclusion criteria were the presence of diabetes, nephropathy, known cardiovascular disease, arrhythmia, and any change in antihypertensive treatment or in treatment with drugs known to influence BP in the 4 weeks preceding and during the study. The protocol was approved by the hospital scientific board and the subjects provided written informed consent for participating in the study.
BP measurements. HBP wrist-monitoring was performed using validated wrist devices fitted with position sensors (Omron R7; Omron Healthcare Europe, Hoofddorp, the Netherlands), [12] [13] [14] which allow measurements to be taken only at heart level. Participants were trained in the conditions of the HBP measurement and the use of the device and were instructed to self-monitor their BP at home for three routine workdays and perform morning measurements (0600-0900 hours, before drug intake if on treatment) and evening measurements (1800-2100 hours), in triplicate, after a 5-min rest in a seated posture and with 1-min intervals between recordings (a total of 18 arm-HBP readings). In accordance with the manufacturer's instructions, they were asked to support their left elbow gently with their right hand and their left hand to be naturally stretched without putting any stress on the fingers. A form was supplied to the participants to report their readings, and these were also printed out through a personal computer linked to the memory of the device.
HBP arm-monitoring measurements were taken using validated oscillometric devices with memory and personal computer link capacity (Omron 705 IT; Omron Healthcare Europe, Hoofddorp, the Netherlands; inflatable bladder 13 × 23 or 15 × 30 cm according to the individual's arm circumference). 18 The participants were trained in the conditions of the HBP measurement and the use of the device in accordance with the manufacturer's instructions (measurements to be taken after a 5-min rest in a seated posture; left elbow bent and supported on a table to bring the cuff to heart level) and were asked to use the same schedule for arm-HBP monitoring as described earlier in relation to the wrist device (triplicate morning and evening measurements for 3 workdays; a total of 18 wrist-HBP readings). Again, participants were asked to report their BP values in a form, and readings were also extracted from the devices' memory. Arm-device HBP and wrist-device HBP were monitored 1 week apart but on the same days of the week (usually from Monday to Wednesday).
ABP monitoring was performed on a routine workday between the two HBP-monitoring sessions (usually on a Thursday). Validated oscillometric devices SpaceLabs 90207 or 90217 were used (SpaceLabs, Redmond, Washington; bladder size 9 × 16 cm or 12 × 23 cm where appropriate). 19 The recorders were programmed to take measurements at 20-min intervals for 24 h. The subjects were instructed to follow their usual daily activities but to remain still with the forearm extended during each reading. A brief diary was supplied to report the times at which they went to bed and got up in the morning during ABP monitoring. Before each ABP-monitoring session, the accuracy of the devices was tested against a standard mercury sphygmomanometer (three succeeding readings; Y connector) in order to ensure that there was no consistent difference of >10 mm Hg in the measured values of BP.
Clinic BP measurements were taken during two visits, at the beginning and at the end of the study. Triplicate measurements were performed at each visit after a 5-min rest in a seated posture, with 1-min intervals between recordings, using a standard mercury sphygmomanometer (bladder size 12 × 24 cm or 15 × 35 cm as appropriate). The second and third measurements at each of the two visits were averaged to arrive at the value of clinic BP for each individual.
Criteria for reliability of wrist-monitored HBP. The criteria used for assessing the reliability of systolic and diastolic wristmonitored HBP measurements were: Statistical analysis. Subjects who monitored their HBP using either of the methods (wrist-monitoring or arm-monitoring) on <3 days, or provided <12 valid measurements, were excluded. Subjects with <30 valid awake ABP measurements were also excluded. The average of all arm-monitored and wristmonitored HBP readings and the average awake ABP were used in the analysis. Awake ABP was calculated using the data provided by the individual subjects regarding their sleeping hours. Statistical analysis was performed using the Minitab statistical software (release 13.31; Minitab, State College, PA). Student's paired t-tests were used for comparing BP values obtained by different methods in the same subjects, with Bonferroni correction for multiple comparisons being applied where appropriate. Bland-Altman scatterplots were used for presenting the differences in average wrist-monitored vs. arm-monitored HBP. Student's unpaired t-tests were used for comparing the differences between wrist-monitored and armmonitored HBP measurements in subgroups of study participants according to age, sex, awake ABP, and pulse pressure, and also the circumference of arm or wrist (depending upon the device used). Pearson correlations were used for investigating the association between the results obtained with the use of the various methods of BP measurement. A probability value P < 0.05 was considered statistically significant.
results
A total of 81 consecutive subjects agreed to participate in the study. Two were subsequently excluded because of inadequate HBP measurements, and the results from the remaining seventy nine subjects were included in the analysis. The mean age of the study group was 56.7 ± 11.8 (s.d.) years, comprising 43 women (54%) and 36 men (46%).Out of the 79 subjects, 46 were on antihypertensive drug treatment (58%). The mean values of various parameters were: height, 168.1 ± 9.6 cm; weight, 79.2 ± 18 kg; body mass index, 27.8 ± 5 kg/m 2 ; arm circumference, 29.8 ± 3.8 cm (range 22-40 cm); and wrist circumference, 17.9 ± 2.2 cm (range 14-24 cm). The average clinic BP of the two study visits was 135.2 ± 13.6/86.8 ± 11 mm Hg (systolic/diastolic).
criteria for reliability of wrist-monitored hBP Criterion 1. The average arm-monitored HBP (132.4 ± 13.0/79.7 ± 9.1 mm Hg) was higher than the average wristmonitored HBP (127.2 ± 11.7/77.5 ± 9.7) by 5.2 ± 9.1 mm Hg for systolic (95% confidence intervals (CIs) 3.2, 7.2, P < 0.001) and 2.2 ± 6.7 mm Hg for diastolic BP (95% CI 0.7, 3.8, P < 0.01). The 40 subjects who used the wrist device first and the arm device second showed arm-monitored and wrist-monitored HBP values that were not significantly different from the 39 subjects who used the devices in the other order. A total of 27 subjects (34%) had a ≥10 mm Hg difference between systolic arm-monitored HBP and wrist-monitored HBP and 12 subjects (15%) showed this difference in respect of the diastolic HBP. In 51 subjects (65%) there was a ≥5 mm Hg difference in systolic HBP measurements depending on the device used, and this difference was found in 38 subjects (48%) in respect of diastolic HBP values (Table 1, Figure 2) . Criterion 2. There were small differences in the s.d. values for average arm-monitored HBP, wrist-monitored HBP, and awake ABP, the highest for systolic BP being that for the armmonitored HBP, and that for diastolic BP being the wristmonitored HBP. articles Wrist Blood Pressure Monitors diastolic) than with wrist-monitored HBP (0.55/0.69) (P < 0.05 for the difference between r values for arm-monitored HBP vs. wrist-monitored HBP for systolic BP). Strong correlations were found between average arm-monitored and wrist-monitored HBP (correlation coefficients r 0.74/0.74, systolic/ diastolic, P < 0.0001). There was no difference between systolic armmonitored HBP and awake ABP (131.3 ± 12.2 mm Hg), whereas diastolic arm-monitored HBP was lower than awake ABP (81.8 ± 9.3 mm Hg) by 2.1 ± 6.4 mm Hg (95% CI 0.7, 3.6, P < 0.01). The average wrist-monitored HBP was lower than the awake ABP by 4.1 ± 11.3 mm Hg (95% CI 1.6, 6.7, P < 0.01) for systolic BP and 4.3 ± 7.5 mm Hg (95% CI 2.6, 6.0, P < 0.001) for diastolic BP.
Factors associated with the wrist-arm hBP difference
The difference in values between arm-monitored and wristmonitored systolic HBP was significantly associated with systolic (r 0.34, P < 0.01), but not diastolic, awake ABP (r 0.15), whereas the difference in values between the arm-monitored and wrist-monitored diastolic HBP was not associated with awake ABP (r −0.03/0.02, systolic/diastolic). The difference between the systolic HBP levels (but not diastolic) as measured by the two devices, was also associated with ambulatory pulse pressure (r 0.29, P < 0.01). No significant correlations were found between the arm-monitored vs. wrist-monitored HBP values and the participants' age, arm or wrist circumference, height, weight, and body mass index. The device-dependent difference in HBP was larger in subjects with awake systolic ABP >135 mm Hg (7.9 ± 9.7 mm Hg) as compared to those with ≤135 mm Hg (3.4 ± 8.3 mm Hg, P < 0.05), and also in subjects with pulse pressure ≥50 mm Hg (7.5 ± 8.2 mm Hg) as compared to those with <50 mm Hg (3.5 ± 9.4 mm Hg, P < 0.05). None of the other characteristics appeared to affect the devicedependent difference in HBP (men vs. women; age <60 years vs. ≥60 years; diastolic awake ABP ≤85 mm Hg vs. >85 mm Hg; arm circumference 22-27 cm vs. 28-32 cm vs. 33-40 cm; and wrist circumference 14-16 cm vs. 17-19 cm vs. 20-24 cm), apart from a trend toward a larger systolic BP difference in those with a smaller arm circumference and a larger diastolic BP difference in women, neither of these trends reaching statistical significance.
discussion
This clinical application study compared HBP measurements taken using validated wrist devices fitted with position sensors with home measurements taken using validated arm devices, and also with awake ABP measurements. The main finding is that, for the purpose of clinical evaluation and decisionmaking, the HBP values recorded with validated wrist devices with position sensors might not correlate with values recorded on arm devices, and that the latter are more closely related to ABP measurements than the wrist-monitored measurements are. The strengths of the study are: (i) it is a randomized clinical application study rather than a study in a research setting; (ii) a relatively large group of participants with a wide range of arm and wrist circumferences was recruited; (iii) validated wrist and arm devices made by the same manufacturer were used, along with memory and personal computer link capacity, so as to prevent reporting bias; 20, 21 and, (iv) ABP values were used as the reference in the comparison. This study found that the differences between HBP values as measured by arm devices and wrist devices are statistically significant and also clinically important, with 34% of participants having a ≥10 mm Hg device-dependent difference in systolic HBP measurements and 22% having such a difference in diastolic HBP (65 and 48%, respectively showed a ≥5 mm Hg difference). In addition, the relationship with ABP was significantly stronger for arm-monitored HBP than for wrist-monitored HBP. It might be argued that the strong association between arm-monitored HBP and ABP is only because these two methods involve measurements taken at the arm level. However, arm-monitored BP remains the fundamental measurement that shows the risks associated with elevated BP and the benefits of antihypertensive treatment, and ABP is regarded as the optimal method for the assessment of the BP load on the heart and vasculature. 3 Three published studies have provided direct comparisons of wrist vs. arm devices 6, 7, 22 A small study in 15 subjects took hourly readings at home, alternating between a wrist device and an arm device (four readings with each). 22 That study found similar average BP values with the two devices as well as similar s.d. values, and concluded that the methods are comparable. Another study in 50 subjects in a clinic setting compared a wrist device (two readings) with an arm device (two readings with the arm supported horizontally at mid-sternal level, and two with the arm supported on a table). 6 That study showed that the wrist-monitored BP measurement was comparable with the arm-monitored BP with the arm at mid-sternal level, whereas it was lower than the arm-monitored BP with the arm supported on a table. The authors stressed the need for a precise definition of arm position during wrist-monitored BP measurement. Only one published study provided a clinical application comparison of wrist vs. arm home measurements in 265 patients with hypertension. 7 That study was similar to ours, in that routine home measurements were obtained with each device for a few days in a randomized order. Their study showed that wrist-monitored HBP was 8/1 mm Hg (systolic/ diastolic) lower than arm-monitored HBP, which is in line with the findings of our study. 7 The authors attributed this difference to uncertainty in the arm position with the use of wrist devices, and discouraged the use of these devices in order to avoid the uncertainty associated with possible improper use. Additional information is provided by our study, because novel wrist devices fitted with position sensors that ensure the standardization of the measurement were used, ABP measurements were used as reference, and factors that could contribute to the difference between wrist-monitored and -monitored HBP were investigated.
It is clear that one of the major issues in the application of wrist devices is the difficulty in standardizing the arm position [6] [7] [8] [9] and that the development of a position sensor is expected to overcome this problem. [10] [11] [12] [13] [14] Interestingly, in this articles Wrist Blood Pressure Monitors study the s.d. values of average arm-monitored and wrist-monitored HBP were similar, thereby indicating that the difference in BP as measured by the two methods should be probably attributed to a systematic rather than a random difference. A systematic error might be attributed to an imperfect algorithm for oscillometric measurement or to a consistent mispositioning of the arm. However, the s.d. of the differences between average wrist-monitored and arm-monitored BP (9.1/6.7 for systolic/diastolic) was slightly higher than those reported for the reproducibility of HBP measured by electronic arm devices (7.0-7.5/4.5-5.0), 23, 24 thereby suggesting that there might be other factors in play, apart from systematic error. Whatever the reason, further work is needed in order to ensure that a more accurate assessment of HBP, that is closer to the established methodology, can be achieved by the use of wrist devices.
The only factors that appeared to be significantly associated with the device-dependent difference in HBP values were the level of ambulatory systolic BP and pulse pressure. Both the arm device and the wrist device used in this study have been shown to fulfill the requirements of the European Society of Hypertension International Protocol. [12] [13] [14] A validation study of the wrist device showed a tendency to underestimate systolic BP at the higher pressures. 13 In the same report, this underestimation was less prominent in obese subjects, 13 which correlates with our finding showing a tendency toward less device-dependent difference in systolic BP in participants with large arm circumferences. This finding (trend for systolic BP underestimation at higher pressures) was also present in a validation study in the elderly by the same investigators, 12 but was not confirmed in a third validation study by a different group. 14 On the other hand, two published validation studies of the arm device used in the study did not show any trend for decreased accuracy at higher systolic pressures. 18, 25 This difference in the accuracy of the devices might explain, at least in part, the larger difference between arm-monitored and wrist-monitored HBP values in subjects with higher systolic BP levels. No other characteristic appeared to be related to the arm-monitored vs. wrist-monitored BP difference, including age, sex, height, weight, body mass index, and arm and wrist circumferences. It might be argued that the nonsignificant trend to a larger difference with smaller arm circumference is not related to the wrist device but is because of alteration in the accuracy of the arm device when different cuffs are used. Unfortunately, this issue is not addressed in the currently used validation protocols. 17 Several validation studies of wrist devices that have been recently published could influence the use of these devices that are already popular. Some wrist devices have been shown to fulfill the validation requirements, 10-16 whereas others did not appear to be accurate. [26] [27] [28] These studies resulted in a change in the recommendation by the European Society of Hypertension and, in the 2007 Guidelines, it is mentioned that "few of the wrist devices have been successfully validated" and that they should be "carefully used at heart level. " 1 It is questionable, however, whether in the case of wrist monitors, formal validation studies performed in strictly controlled conditions of a research setting are adequate for the values to be accepted in clinical practice. Clinical application studies might also be needed to show whether wrist devices can produce accurate BP measurements in real-life conditions, and whether such measurements can provide information of comparable quality to arm-monitored measurements, which are established predictors of cardiovascular risk.
In summary, the findings of this study suggest that, despite the considerable technological advancements in the development of wrist devices, caution is required in their use in clinical practice. Validated wrist devices with position sensors might often lead to significant underestimation of BP, particularly systolic BP. Wrist devices might need further technological improvements and be subjected to further clinical research before they can be recommended for widespread use in clinical practice.
